معرفی
Professor Mark S Cooper is a distinguished academic at the University of Sydney, serving as Professor of Medicine and Head of the Concord Clinical School. His research focuses on glucocorticoid metabolism and its impacts on bone health, inflammatory diseases, and critical care endocrinology. He is affiliated with the Charles Perkins Centre and collaborates internationally with institutions in Germany (Charite University Hospital) and the UK (University of Birmingham).
Research Interests include:
- 11β-hydroxysteroid dehydrogenase enzymes
- Steroid hormone action in bone and joint disease
- Translational approaches to arthritis and osteoporosis
- Adrenal dysfunction in critical illness
Recent Publications highlight his work on glucocorticoid metabolism in inflammatory conditions, burn wound healing, and corticosteroid therapy optimization. Key scientific awards include Fellowships from the Royal College of Physicians and Royal Australasian College of Physicians, alongside leadership roles in clinical guidelines development.
Grants include funding for advanced imaging systems and collaborations with institutions in Australia and abroad. His work bridges basic science and clinical applications in endocrinology and rheumatology.